SARA REEVES: Open Payments
NPI 1093147449 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 15 payments from 8 companies in 2025. Trend: 2023 $276 · 2024 $640 · 2025 $614
Food & beverage: $514Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $174 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $100 |
| ABBVIE INC. | 3 | $77 |
| Novo Nordisk Inc | 2 | $60 |
| Amgen Inc. | 2 | $35 |
| Abbott Laboratories | 1 | $27 |
| Exact Sciences Corporation | 1 | $17 |
Products named: AIRSUPRA, UPTRAVI, Wegovy, QULIPTA, BREZTRI, FREESTYLE LIBRE 3, UBRELVY, OTEZLA.
Industry payments across AZ — which companies pay providers there.
